Structure

Physi-Chem Properties

Molecular Weight:  398.25
Volume:  440.549
LogP:  4.967
LogD:  4.828
LogS:  -4.873
# Rotatable Bonds:  11
TPSA:  66.74
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.315
Synthetic Accessibility Score:  4.123
Fsp3:  0.44
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.79
MDCK Permeability:  2.5665398425189778e-05
Pgp-inhibitor:  0.005
Pgp-substrate:  0.049
Human Intestinal Absorption (HIA):  0.006
20% Bioavailability (F20%):  0.003
30% Bioavailability (F30%):  0.002

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.014
Plasma Protein Binding (PPB):  98.60832214355469%
Volume Distribution (VD):  1.61
Pgp-substrate:  1.0859934091567993%

ADMET: Metabolism

CYP1A2-inhibitor:  0.362
CYP1A2-substrate:  0.644
CYP2C19-inhibitor:  0.792
CYP2C19-substrate:  0.137
CYP2C9-inhibitor:  0.77
CYP2C9-substrate:  0.986
CYP2D6-inhibitor:  0.9
CYP2D6-substrate:  0.91
CYP3A4-inhibitor:  0.716
CYP3A4-substrate:  0.251

ADMET: Excretion

Clearance (CL):  6.751
Half-life (T1/2):  0.61

ADMET: Toxicity

hERG Blockers:  0.004
Human Hepatotoxicity (H-HT):  0.674
Drug-inuced Liver Injury (DILI):  0.875
AMES Toxicity:  0.007
Rat Oral Acute Toxicity:  0.876
Maximum Recommended Daily Dose:  0.144
Skin Sensitization:  0.303
Carcinogencity:  0.364
Eye Corrosion:  0.003
Eye Irritation:  0.171
Respiratory Toxicity:  0.966

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475818

Natural Product ID:  NPC475818
Common Name*:   Isopalinurin
IUPAC Name:   (2R)-2-[(2E,4E,10E)-13-(furan-3-yl)-2,6,10-trimethyltrideca-2,4,10-trienyl]-3-hydroxy-4-methyl-2H-furan-5-one
Synonyms:   Isopalinurin
Standard InCHIKey:  PZPXBUTUKYKUCW-KKGPLOBWSA-N
Standard InCHI:  InChI=1S/C25H34O4/c1-18(8-5-9-19(2)11-7-13-22-14-15-28-17-22)10-6-12-20(3)16-23-24(26)21(4)25(27)29-23/h6,10-12,14-15,17-18,23,26H,5,7-9,13,16H2,1-4H3/b10-6+,19-11+,20-12+/t18?,23-/m1/s1
SMILES:  CC(/C=C/C=C(/C[C@H]1OC(=O)C(=C1O)C)C)CCC/C(=C/CCc1cocc1)/C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL516676
PubChem CID:   54726685
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001283] Terpene lactones
          • [CHEMONTID:0001538] Diterpene lactones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33102 psammocinia sp. Species Irciniidae Eukaryota n.a. n.a. n.a. PMID[15270579]
NPO33102 psammocinia sp. Species Irciniidae Eukaryota n.a. Korean n.a. PMID[23489626]
NPO33102 psammocinia sp. Species Irciniidae Eukaryota n.a. n.a. n.a. PMID[28621941]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT81 Cell Line A549 Homo sapiens ED50 > 30.0 ug ml-1 PMID[547822]
NPT146 Cell Line SK-OV-3 Homo sapiens ED50 = 16.5 ug ml-1 PMID[547822]
NPT147 Cell Line SK-MEL-2 Homo sapiens ED50 = 10.7 ug ml-1 PMID[547822]
NPT574 Cell Line XF498 Homo sapiens ED50 = 10.0 ug ml-1 PMID[547822]
NPT148 Cell Line HCT-15 Homo sapiens ED50 > 30.0 ug ml-1 PMID[547822]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475818 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9746 High Similarity NPC329694
0.9746 High Similarity NPC81912
0.9746 High Similarity NPC329922
0.9746 High Similarity NPC474260
0.9741 High Similarity NPC289911
0.9741 High Similarity NPC283284
0.9739 High Similarity NPC474817
0.9655 High Similarity NPC474136
0.95 High Similarity NPC476016
0.9496 High Similarity NPC71274
0.9496 High Similarity NPC75557
0.9492 High Similarity NPC476351
0.9421 High Similarity NPC474438
0.9421 High Similarity NPC474279
0.9339 High Similarity NPC474830
0.931 High Similarity NPC131801
0.9174 High Similarity NPC474829
0.9153 High Similarity NPC473969
0.9016 High Similarity NPC471559
0.8983 High Similarity NPC144745
0.8983 High Similarity NPC208906
0.8889 High Similarity NPC17681
0.8879 High Similarity NPC1811
0.8879 High Similarity NPC26157
0.8871 High Similarity NPC471554
0.8871 High Similarity NPC473355
0.8871 High Similarity NPC471573
0.8871 High Similarity NPC471501
0.8828 High Similarity NPC288209
0.8819 High Similarity NPC97740
0.8793 High Similarity NPC105249
0.877 High Similarity NPC471549
0.877 High Similarity NPC473379
0.8696 High Similarity NPC471521
0.8696 High Similarity NPC473356
0.8689 High Similarity NPC1848
0.8678 High Similarity NPC4898
0.8672 High Similarity NPC45358
0.8626 High Similarity NPC215109
0.8626 High Similarity NPC170604
0.8615 High Similarity NPC14650
0.8605 High Similarity NPC474425
0.8605 High Similarity NPC474426
0.8605 High Similarity NPC474407
0.8595 High Similarity NPC187547
0.8595 High Similarity NPC21831
0.8571 High Similarity NPC137570
0.848 Intermediate Similarity NPC243269
0.8468 Intermediate Similarity NPC263870
0.8462 Intermediate Similarity NPC177331
0.8409 Intermediate Similarity NPC303217
0.8222 Intermediate Similarity NPC107571
0.8203 Intermediate Similarity NPC138139
0.8203 Intermediate Similarity NPC46536
0.8197 Intermediate Similarity NPC28054
0.8189 Intermediate Similarity NPC118853
0.8189 Intermediate Similarity NPC188377
0.8189 Intermediate Similarity NPC65735
0.8175 Intermediate Similarity NPC477967
0.8168 Intermediate Similarity NPC89133
0.814 Intermediate Similarity NPC83178
0.8106 Intermediate Similarity NPC471544
0.8106 Intermediate Similarity NPC473344
0.8106 Intermediate Similarity NPC471545
0.8077 Intermediate Similarity NPC207294
0.8077 Intermediate Similarity NPC112706
0.8074 Intermediate Similarity NPC473268
0.8065 Intermediate Similarity NPC312525
0.8065 Intermediate Similarity NPC217180
0.806 Intermediate Similarity NPC159786
0.8058 Intermediate Similarity NPC267004
0.8058 Intermediate Similarity NPC218712
0.8058 Intermediate Similarity NPC307346
0.8058 Intermediate Similarity NPC261733
0.7984 Intermediate Similarity NPC179354
0.797 Intermediate Similarity NPC471817
0.797 Intermediate Similarity NPC473982
0.7969 Intermediate Similarity NPC16922
0.7956 Intermediate Similarity NPC90953
0.7953 Intermediate Similarity NPC79557
0.7943 Intermediate Similarity NPC104924
0.7926 Intermediate Similarity NPC476947
0.792 Intermediate Similarity NPC227660
0.791 Intermediate Similarity NPC218838
0.7907 Intermediate Similarity NPC477965
0.7907 Intermediate Similarity NPC477038
0.7903 Intermediate Similarity NPC205523
0.7902 Intermediate Similarity NPC234494
0.7895 Intermediate Similarity NPC298190
0.7895 Intermediate Similarity NPC136340
0.7891 Intermediate Similarity NPC317217
0.7863 Intermediate Similarity NPC95567
0.7863 Intermediate Similarity NPC319140
0.7857 Intermediate Similarity NPC291619
0.7857 Intermediate Similarity NPC80635
0.7857 Intermediate Similarity NPC243704
0.7857 Intermediate Similarity NPC254958
0.7857 Intermediate Similarity NPC254198
0.784 Intermediate Similarity NPC45536
0.781 Intermediate Similarity NPC186626
0.7794 Intermediate Similarity NPC92941
0.7786 Intermediate Similarity NPC216810
0.7786 Intermediate Similarity NPC121158
0.7786 Intermediate Similarity NPC23086
0.7786 Intermediate Similarity NPC74612
0.7778 Intermediate Similarity NPC470740
0.7778 Intermediate Similarity NPC125182
0.7778 Intermediate Similarity NPC69647
0.7762 Intermediate Similarity NPC255414
0.7761 Intermediate Similarity NPC61788
0.776 Intermediate Similarity NPC150895
0.7746 Intermediate Similarity NPC34056
0.774 Intermediate Similarity NPC33938
0.774 Intermediate Similarity NPC121615
0.774 Intermediate Similarity NPC294511
0.7737 Intermediate Similarity NPC146872
0.773 Intermediate Similarity NPC267632
0.7724 Intermediate Similarity NPC470997
0.7721 Intermediate Similarity NPC106247
0.7708 Intermediate Similarity NPC7388
0.7698 Intermediate Similarity NPC476014
0.7698 Intermediate Similarity NPC476031
0.7698 Intermediate Similarity NPC202260
0.7687 Intermediate Similarity NPC253201
0.7687 Intermediate Similarity NPC98206
0.7687 Intermediate Similarity NPC34421
0.7687 Intermediate Similarity NPC237259
0.7687 Intermediate Similarity NPC302054
0.7687 Intermediate Similarity NPC21460
0.7681 Intermediate Similarity NPC470742
0.768 Intermediate Similarity NPC292036
0.7676 Intermediate Similarity NPC251865
0.7676 Intermediate Similarity NPC137295
0.7669 Intermediate Similarity NPC477123
0.7669 Intermediate Similarity NPC477966
0.7669 Intermediate Similarity NPC477039
0.7669 Intermediate Similarity NPC477040
0.7651 Intermediate Similarity NPC472777
0.7651 Intermediate Similarity NPC472778
0.7651 Intermediate Similarity NPC472776
0.7643 Intermediate Similarity NPC56197
0.7639 Intermediate Similarity NPC216755
0.7639 Intermediate Similarity NPC471174
0.7635 Intermediate Similarity NPC296807
0.7635 Intermediate Similarity NPC155939
0.7635 Intermediate Similarity NPC141538
0.7634 Intermediate Similarity NPC130275
0.763 Intermediate Similarity NPC475092
0.7626 Intermediate Similarity NPC236532
0.7622 Intermediate Similarity NPC195920
0.7619 Intermediate Similarity NPC474378
0.7619 Intermediate Similarity NPC474219
0.7619 Intermediate Similarity NPC472672
0.7619 Intermediate Similarity NPC268905
0.7615 Intermediate Similarity NPC174915
0.7615 Intermediate Similarity NPC270807
0.7612 Intermediate Similarity NPC120836
0.7612 Intermediate Similarity NPC223063
0.7606 Intermediate Similarity NPC476946
0.7606 Intermediate Similarity NPC22248
0.7603 Intermediate Similarity NPC228842
0.7586 Intermediate Similarity NPC93666
0.7586 Intermediate Similarity NPC471007
0.7578 Intermediate Similarity NPC293424
0.7569 Intermediate Similarity NPC346
0.7559 Intermediate Similarity NPC474987
0.7559 Intermediate Similarity NPC76844
0.7556 Intermediate Similarity NPC476925
0.7554 Intermediate Similarity NPC310830
0.7552 Intermediate Similarity NPC476944
0.7541 Intermediate Similarity NPC140688
0.7537 Intermediate Similarity NPC476917
0.7537 Intermediate Similarity NPC26532
0.7537 Intermediate Similarity NPC327527
0.7537 Intermediate Similarity NPC329707
0.7535 Intermediate Similarity NPC52412
0.7534 Intermediate Similarity NPC472654
0.7533 Intermediate Similarity NPC88007
0.7533 Intermediate Similarity NPC7059
0.7533 Intermediate Similarity NPC197137
0.7533 Intermediate Similarity NPC194499
0.752 Intermediate Similarity NPC22678
0.7519 Intermediate Similarity NPC244862
0.7519 Intermediate Similarity NPC67345
0.7518 Intermediate Similarity NPC201370
0.7518 Intermediate Similarity NPC67003
0.7518 Intermediate Similarity NPC282973
0.7518 Intermediate Similarity NPC148374
0.7518 Intermediate Similarity NPC473983
0.7517 Intermediate Similarity NPC250228
0.7517 Intermediate Similarity NPC92979
0.7517 Intermediate Similarity NPC302987
0.7517 Intermediate Similarity NPC71821
0.7517 Intermediate Similarity NPC281258
0.7517 Intermediate Similarity NPC214541
0.7517 Intermediate Similarity NPC476938
0.7517 Intermediate Similarity NPC44675
0.7517 Intermediate Similarity NPC476937
0.75 Intermediate Similarity NPC220094
0.75 Intermediate Similarity NPC477645

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475818 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7447 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD6355 Discontinued
0.7292 Intermediate Similarity NPD4628 Phase 3
0.7206 Intermediate Similarity NPD5647 Approved
0.7164 Intermediate Similarity NPD9717 Approved
0.7122 Intermediate Similarity NPD6798 Discontinued
0.712 Intermediate Similarity NPD1358 Approved
0.7101 Intermediate Similarity NPD6832 Phase 2
0.7099 Intermediate Similarity NPD9092 Discovery
0.7042 Intermediate Similarity NPD6653 Approved
0.704 Intermediate Similarity NPD3134 Approved
0.695 Remote Similarity NPD6233 Phase 2
0.695 Remote Similarity NPD4062 Phase 3
0.6948 Remote Similarity NPD5761 Phase 2
0.6948 Remote Similarity NPD5760 Phase 2
0.6944 Remote Similarity NPD2799 Discontinued
0.6906 Remote Similarity NPD9494 Approved
0.6884 Remote Similarity NPD2797 Approved
0.6884 Remote Similarity NPD1203 Approved
0.6884 Remote Similarity NPD6362 Approved
0.6884 Remote Similarity NPD1049 Clinical (unspecified phase)
0.6871 Remote Similarity NPD7421 Clinical (unspecified phase)
0.6853 Remote Similarity NPD447 Suspended
0.6846 Remote Similarity NPD7843 Approved
0.6839 Remote Similarity NPD7096 Clinical (unspecified phase)
0.6835 Remote Similarity NPD1019 Discontinued
0.6822 Remote Similarity NPD2181 Clinical (unspecified phase)
0.6821 Remote Similarity NPD6273 Approved
0.68 Remote Similarity NPD6799 Approved
0.6797 Remote Similarity NPD2684 Approved
0.6794 Remote Similarity NPD1241 Discontinued
0.6791 Remote Similarity NPD9545 Approved
0.6781 Remote Similarity NPD1551 Phase 2
0.6779 Remote Similarity NPD3887 Approved
0.6779 Remote Similarity NPD2354 Approved
0.6761 Remote Similarity NPD2313 Discontinued
0.6761 Remote Similarity NPD3268 Approved
0.6759 Remote Similarity NPD7097 Phase 1
0.6742 Remote Similarity NPD690 Clinical (unspecified phase)
0.6736 Remote Similarity NPD1933 Approved
0.6735 Remote Similarity NPD6005 Phase 3
0.6735 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6735 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6735 Remote Similarity NPD6002 Phase 3
0.6735 Remote Similarity NPD6004 Phase 3
0.6727 Remote Similarity NPD6765 Approved
0.6727 Remote Similarity NPD6764 Approved
0.6726 Remote Similarity NPD8434 Phase 2
0.6719 Remote Similarity NPD290 Approved
0.6715 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6712 Remote Similarity NPD4308 Phase 3
0.6711 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6711 Remote Similarity NPD4110 Phase 3
0.6709 Remote Similarity NPD7075 Discontinued
0.6692 Remote Similarity NPD7157 Approved
0.6691 Remote Similarity NPD1778 Approved
0.669 Remote Similarity NPD7095 Approved
0.6689 Remote Similarity NPD5958 Discontinued
0.6689 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6667 Remote Similarity NPD5403 Approved
0.6667 Remote Similarity NPD1608 Approved
0.6667 Remote Similarity NPD1894 Discontinued
0.6645 Remote Similarity NPD5401 Approved
0.6645 Remote Similarity NPD6599 Discontinued
0.6643 Remote Similarity NPD411 Approved
0.6643 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6642 Remote Similarity NPD9493 Approved
0.6642 Remote Similarity NPD3496 Discontinued
0.6627 Remote Similarity NPD6559 Discontinued
0.6623 Remote Similarity NPD7440 Discontinued
0.6622 Remote Similarity NPD5763 Approved
0.6622 Remote Similarity NPD5762 Approved
0.6622 Remote Similarity NPD2344 Approved
0.6621 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6618 Remote Similarity NPD5585 Approved
0.6615 Remote Similarity NPD2067 Discontinued
0.6601 Remote Similarity NPD5049 Phase 3
0.6599 Remote Similarity NPD7033 Discontinued
0.6596 Remote Similarity NPD2798 Approved
0.6581 Remote Similarity NPD7458 Discontinued
0.6581 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6577 Remote Similarity NPD4534 Discontinued
0.6568 Remote Similarity NPD6785 Approved
0.6568 Remote Similarity NPD6784 Approved
0.6561 Remote Similarity NPD6801 Discontinued
0.6558 Remote Similarity NPD920 Approved
0.6554 Remote Similarity NPD2239 Approved
0.6554 Remote Similarity NPD2935 Discontinued
0.6554 Remote Similarity NPD2240 Approved
0.6552 Remote Similarity NPD4060 Phase 1
0.6552 Remote Similarity NPD4307 Phase 2
0.6536 Remote Similarity NPD4661 Approved
0.6536 Remote Similarity NPD4662 Approved
0.6525 Remote Similarity NPD3266 Approved
0.6525 Remote Similarity NPD3267 Approved
0.6522 Remote Similarity NPD3847 Discontinued
0.6515 Remote Similarity NPD969 Suspended
0.6513 Remote Similarity NPD643 Clinical (unspecified phase)
0.651 Remote Similarity NPD2353 Approved
0.651 Remote Similarity NPD2346 Discontinued
0.651 Remote Similarity NPD2355 Clinical (unspecified phase)
0.65 Remote Similarity NPD4379 Clinical (unspecified phase)
0.6479 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6467 Remote Similarity NPD2424 Discontinued
0.6466 Remote Similarity NPD5535 Approved
0.646 Remote Similarity NPD5537 Clinical (unspecified phase)
0.646 Remote Similarity NPD919 Approved
0.6458 Remote Similarity NPD5952 Clinical (unspecified phase)
0.6454 Remote Similarity NPD1876 Approved
0.6454 Remote Similarity NPD3225 Approved
0.6449 Remote Similarity NPD17 Approved
0.6447 Remote Similarity NPD2309 Approved
0.6443 Remote Similarity NPD6032 Approved
0.6438 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6434 Remote Similarity NPD9697 Approved
0.6429 Remote Similarity NPD642 Clinical (unspecified phase)
0.6429 Remote Similarity NPD1481 Phase 2
0.6429 Remote Similarity NPD3972 Approved
0.6415 Remote Similarity NPD1006 Clinical (unspecified phase)
0.6415 Remote Similarity NPD7819 Suspended
0.6414 Remote Similarity NPD3764 Approved
0.6412 Remote Similarity NPD2182 Approved
0.6408 Remote Similarity NPD987 Approved
0.6392 Remote Similarity NPD6677 Suspended
0.6392 Remote Similarity NPD7411 Suspended
0.6389 Remote Similarity NPD2614 Approved
0.6383 Remote Similarity NPD4359 Approved
0.6382 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6382 Remote Similarity NPD7003 Approved
0.6382 Remote Similarity NPD3750 Approved
0.638 Remote Similarity NPD8127 Discontinued
0.6375 Remote Similarity NPD5402 Approved
0.6364 Remote Similarity NPD4575 Clinical (unspecified phase)
0.6358 Remote Similarity NPD1549 Phase 2
0.6357 Remote Similarity NPD1535 Discovery
0.635 Remote Similarity NPD5536 Phase 2
0.6338 Remote Similarity NPD1283 Approved
0.6335 Remote Similarity NPD7768 Phase 2
0.6335 Remote Similarity NPD3882 Suspended
0.6333 Remote Similarity NPD2438 Suspended
0.6333 Remote Similarity NPD4477 Approved
0.6333 Remote Similarity NPD2796 Approved
0.6333 Remote Similarity NPD1501 Clinical (unspecified phase)
0.6333 Remote Similarity NPD5712 Approved
0.6333 Remote Similarity NPD4476 Approved
0.6327 Remote Similarity NPD4140 Approved
0.6327 Remote Similarity NPD3142 Approved
0.6327 Remote Similarity NPD3140 Approved
0.6323 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6319 Remote Similarity NPD454 Approved
0.6316 Remote Similarity NPD1243 Approved
0.6301 Remote Similarity NPD1048 Approved
0.6299 Remote Similarity NPD1238 Approved
0.6296 Remote Similarity NPD4381 Clinical (unspecified phase)
0.6291 Remote Similarity NPD6800 Clinical (unspecified phase)
0.6291 Remote Similarity NPD1471 Phase 3
0.6291 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6291 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6289 Remote Similarity NPD958 Approved
0.6284 Remote Similarity NPD4622 Approved
0.6284 Remote Similarity NPD4618 Approved
0.6284 Remote Similarity NPD230 Phase 1
0.6284 Remote Similarity NPD4340 Discontinued
0.6279 Remote Similarity NPD6647 Phase 2
0.6275 Remote Similarity NPD1878 Clinical (unspecified phase)
0.6273 Remote Similarity NPD5616 Clinical (unspecified phase)
0.6273 Remote Similarity NPD3817 Phase 2
0.6268 Remote Similarity NPD3685 Discontinued
0.6267 Remote Similarity NPD3748 Approved
0.6266 Remote Similarity NPD2651 Approved
0.6266 Remote Similarity NPD2649 Approved
0.6259 Remote Similarity NPD8032 Phase 2
0.6259 Remote Similarity NPD5691 Approved
0.625 Remote Similarity NPD2629 Approved
0.625 Remote Similarity NPD7596 Clinical (unspecified phase)
0.625 Remote Similarity NPD2897 Discontinued
0.625 Remote Similarity NPD1934 Approved
0.6242 Remote Similarity NPD6980 Clinical (unspecified phase)
0.6242 Remote Similarity NPD6808 Phase 2
0.6241 Remote Similarity NPD1091 Approved
0.6233 Remote Similarity NPD2598 Clinical (unspecified phase)
0.6226 Remote Similarity NPD4380 Phase 2
0.6216 Remote Similarity NPD2979 Phase 3
0.6214 Remote Similarity NPD4626 Approved
0.6211 Remote Similarity NPD8455 Phase 2
0.6211 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6209 Remote Similarity NPD2976 Clinical (unspecified phase)
0.6209 Remote Similarity NPD1652 Phase 2
0.6202 Remote Similarity NPD291 Approved
0.62 Remote Similarity NPD5688 Approved
0.62 Remote Similarity NPD5689 Approved
0.6196 Remote Similarity NPD3749 Approved
0.6196 Remote Similarity NPD8005 Clinical (unspecified phase)
0.6194 Remote Similarity NPD6652 Clinical (unspecified phase)
0.619 Remote Similarity NPD7893 Clinical (unspecified phase)
0.619 Remote Similarity NPD3818 Discontinued
0.619 Remote Similarity NPD2163 Approved
0.6182 Remote Similarity NPD7199 Phase 2
0.6178 Remote Similarity NPD2186 Approved
0.6174 Remote Similarity NPD5124 Phase 1

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data